NCT02908906
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02908906
Title A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | GBR | ESP

Facility Status City State Zip Country Details
St Louis Missouri United States Details
Pittsburgh Pennsylvania United States Details
Chisinau Moldova Details
Bialystok Poland Details
Warsaw Poland Details
Moscow Russia Details
Pyatigorsk Russia Details
Saint Petersburg Russia Details
Badalona Spain Details
Barcelona Spain Details
Madrid Spain Details
Málaga Spain Details
Pamplona Spain Details
Seville Spain Details
Valencia Spain Details
Gothenburg Sweden Details
Glasgow United Kingdom Details
London United Kingdom Details
Manchester United Kingdom Details
Newcastle upon Tyne United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field